Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
740MO Dostarlimab + chemotherapy for the treatment of primary advanced or recurrent endometrial cancer (pA/rEC): Analysis of progression free survival (PFS) and overall survival (OS) outcomes by molecular classification in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Mansoor Raza Mirza, Sudarshan Kumar Sharma, Jørn Herrstedt, Mark S. Shahin, David Cibula, Emily Fleming and 14 more
- Rank
- 94 of 3,639
- Percentile
- top 2.6%
- Where
- Annals of Oncology, 2023
- Citations
- 32
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.